SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:gup.ub.gu.se/197810"
 

Search: onr:"swepub:oai:gup.ub.gu.se/197810" > Nilotinib versus im...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.

Saglio, Giuseppe (author)
Kim, Dong-Wook (author)
Issaragrisil, Surapol (author)
show more...
le Coutre, Philipp (author)
Etienne, Gabriel (author)
Lobo, Clarisse (author)
Pasquini, Ricardo (author)
Clark, Richard E (author)
Hochhaus, Andreas (author)
Hughes, Timothy P (author)
Gallagher, Neil (author)
Hoenekopp, Albert (author)
Dong, Mei (author)
Haque, Ariful (author)
Larson, Richard A (author)
Kantarjian, Hagop M (author)
Wadenvik, Hans, 1955 (author)
Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för invärtesmedicin,Institute of Medicine, Department of Internal Medicine
show less...
 (creator_code:org_t)
2010
2010
English.
In: The New England journal of medicine. - 1533-4406. ; 362:24, s. 2251-9
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Nilotinib has been shown to be a more potent inhibitor of BCR-ABL than imatinib. We evaluated the efficacy and safety of nilotinib, as compared with imatinib, in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (CML) in the chronic phase.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Keyword

Adolescent
Adult
Aged
Aged
80 and over
Antineoplastic Agents
administration & dosage
adverse effects
therapeutic use
Benzamides
Blast Crisis
prevention & control
Disease Progression
Female
Fusion Proteins
bcr-abl
antagonists & inhibitors
Humans
Kaplan-Meier Estimate
Leukemia
Myeloid
Chronic-Phase
drug therapy
pathology
Male
Middle Aged
Piperazines
adverse effects
therapeutic use
Protein Kinase Inhibitors
administration & dosage
adverse effects
therapeutic use
Pyrimidines
administration & dosage
adverse effects
therapeutic use
Young Adult

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view